OXLUMO® (lumasiran) Launch wins ELITE 2021 Award

Greater Than One (GTO) has been recognized by PM360 for its success in conceiving and launching a virtual campaign to support OXLUMO® (lumasiran), a first-in-class therapy developed by Alnylam.